ArticleCancer management and research2026
Severe Immune-Related Adverse Events Associated with Durable Antitumor Responses Following Immune Checkpoint Inhibitor Therapy: Two Case Reports.
Qunxiang Chen et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.